Checkpoint Therapeutics, Inc.: Wedbush still on the buy







Marketzone with MT Newswires 2022

All the news about CHECKPOINT THERAPEUTICS, INC.

Analyst Recommendations for CHECKPOINT THERAPEUTICS, INC.

2022 turnover 0.12M
–
0.12M
2022 net result -61.0M
–
-60.6M
Net debt 2022 –
–
–
PER 2022-1.65x
2022 return–
Capitalization 111M
111M
110M
capi. / CA 2022916x
capi. / CA 20231,844x
Number of employees14
Floating84.4%

Chart CHECKPOINT THERAPEUTICS, INC.


Hard :

Period:




Checkpoint Therapeutics, Inc.: Checkpoint Therapeutics, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis CHECKPOINT THERAPEUTICS, INC.

Short termMiddle termLong term
Trendsbearishbearishbearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts5
Last Closing Price$1.13
Average price target$19.80
Deviation / Average Target1,652%

Officers and Directors




Source link -88